Futibatinib and Pembrolizumab Combination in the Treatment of Advanced or Metastatic Urothelial Carcinoma
Clinical trial NCT04601857 · TERMINATED
Trial details
- NCT number
- NCT04601857
- Sponsor
- Taiho Oncology, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-07
- Primary completion
- 2024-03-08
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.